Chaperone-Like Therapy with Tetrahydrobiopterin in Clinical Trials for Phenylketonuria: Is Genotype a Predictor of Response?

Prospectively enrolled phenylketonuria patients (n=485) participated in an international Phase II clinical trial to identify the prevalence of a therapeutic response to daily doses of sapropterin dihydrochloride (sapropterin, KUVAN(®)). Responsive patients were then enrolled in two subsequent Phase...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sarkissian, Christineh N., Gamez, Alejandra, Scott, Patrick, Dauvillier, Jerome, Dorenbaum, Alejandro, Scriver, Charles R., Stevens, Raymond C.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3509924/
https://ncbi.nlm.nih.gov/pubmed/23430918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2011_96
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados